Search

Your search for "Chronic lymphocytic leukemia" gave back 1099 results.
Uramustine (CAS 66-75-1), also known as uracil mustard, is a chemotherapy drug which belongs to the class of alkylating agents. The “Uramustine...
LPI
March 2023
Price: USD 3,660.00
Uramustine (CAS 66-75-1), also known as uracil mustard, is a chemotherapy drug which belongs to the class of alkylating agents. The global Uramustine...
MRRPB5
April 2023
Price: USD 2,900.00
Uramustine (CAS 66-75-1), also known as uracil mustard, is a chemotherapy drug which belongs to the class of alkylating agents. The global Uramustine...
MRRPB5
August 2023
Price: USD 4,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
LPI
January 2023
Price: USD 3,660.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
GIR
February 2023
Price: USD 3,480.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
MRRPB5
January 2023
Price: USD 2,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
MRRPB5
June 2023
Price: USD 4,900.00
Summary Publisher estimates that the Ibrutinib market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog: 
HYR
April 2021
Price: USD 2,000.00
Venetoclax(CAS:1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic...
LPI
February 2023
Price: USD 3,660.00
Summary Publisher estimates that the PEGylated Proteins market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog: 
HYR
May 2021
Price: USD 2,000.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
LPI
February 2023
Price: USD 3,660.00
Venetoclax(CAS:1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic...
MRRPB5
May 2023
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
MRRPB5
February 2024
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
MRRPB5
February 2023
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
GIR
February 2023
Price: USD 3,480.00

Contact Us for Custom Market Research Solutions

 

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected